Follow
Shingo Suzuki
Shingo Suzuki
University of Texas, HSC at Houston
Verified email at uth.tmc.edu
Title
Cited by
Cited by
Year
Derivation of airway basal stem cells from human pluripotent stem cells
FJ Hawkins, S Suzuki, ML Beermann, C Barillà, R Wang, ...
Cell stem cell 28 (1), 79-95. e8, 2021
1522021
Highly efficient gene editing of cystic fibrosis patient-derived airway basal cells results in functional CFTR correction
S Suzuki, AM Crane, V Anirudhan, C Barillà, N Matthias, SH Randell, ...
Molecular Therapy 28 (7), 1684-1695, 2020
552020
TALENs Facilitate Single-step Seamless SDF Correction of F508del CFTR in Airway Epithelial Submucosal Gland Cell-derived CF-iPSCs
S Suzuki, RG Sargent, B Illek, H Fischer, A Esmaeili-Shandiz, MJ Yezzi, ...
Molecular Therapy Nucleic Acids, 2016
472016
Synergism between interleukin (IL)-17 and toll-like receptor 2 and 4 signals to induce IL-8 expression in cystic fibrosis airway epithelial cells
S Mizunoe, T Shuto, S Suzuki, C Matsumoto, K Watanabe, K Ueno-Shuto, ...
Journal of pharmacological sciences 118 (4), 512-520, 2012
332012
Posttranslational negative regulation of glycosylated and non-glycosylated BCRP expression by Derlin-1
T Sugiyama, T Shuto, S Suzuki, T Sato, T Koga, MA Suico, H Kusuhara, ...
Biochemical and biophysical research communications 404 (3), 853-858, 2011
312011
Lucidenic acids-rich extract from antlered form of Ganoderma lucidum enhances TNFα induction in THP-1 monocytic cells possibly via its modulation of MAP kinases p38 and JNK
K Watanabe, T Shuto, M Sato, K Onuki, S Mizunoe, S Suzuki, T Sato, ...
Biochemical and biophysical research communications 408 (1), 18-24, 2011
262011
Correction of airway stem cells: Genome editing approaches for the treatment of cystic fibrosis
NE King, S Suzuki, C Barilla, FJ Hawkins, SH Randell, SD Reynolds, ...
Human Gene Therapy 31 (17-18), 956-972, 2020
242020
Inhibition of post-translational N-glycosylation by HRD1 that controls the fate of ABCG5/8 transporter
S Suzuki, T Shuto, T Sato, M Kaneko, T Takada, MA Suico, DM Cyr, ...
Scientific reports 4 (1), 1-14, 2014
212014
Nuclease-mediated double-strand break (DSB) enhancement of small fragment homologous recombination (SFHR) gene modification in human-induced pluripotent stem cells (hiPSCs)
RG Sargent, S Suzuki, DC Gruenert
Gene Correction, 279-290, 2014
202014
Integrative expression analysis identifies a novel interplay between CFTR and linc-SUMF1-2 that involves CF-associated gene dysregulation
S Kamei, K Maruta, H Fujikawa, H Nohara, K Ueno-Shuto, Y Tasaki, ...
Biochemical and biophysical research communications 509 (2), 521-528, 2019
92019
Targeted Gene Insertion for Functional CFTR Restoration in Airway Epithelium
C Barillà, S Suzuki, A Rab, EJ Sorscher, B Davis
Frontiers in Genome Editing, 13, 2022
22022
Directed Differentiation of Human Induced Pluripotent Stem (hiPS) Cells into Functional Parathyroid Tissue for Cell Therapy
AE Shandiz, A Lee, S Suzuki, RG Sargent, MH Yezzi, LA Orloff, ...
MOLECULAR THERAPY 21, S181-S182, 2013
22013
122. Seamless Correction by Donor DNA of a Class I CFTR Mutation Facilitated by a Double Nicking CRISPR/Cas9 in CF-iPSCs
S Suzuki, K Chosa, A Lee, M Yezzi, H Kai, D Gruenert
Molecular Therapy 24, S51, 2016
12016
572: Clinical and iPSC-derived airway epithelial responses to elexacaftor/tezacaftor/ivacaftor in CF patients without an approved modulator
R Linnemann, G Solomon, A Streby, A Rab, W Driggers, K Slaten, ...
Journal of Cystic Fibrosis 20, S271, 2021
2021
638: Demonstration of pharmacologic N1303 K CFTR rescue in heterologous and human tissue-based model systems
J Brewington, J Hong, C Manfredi, A Rab, D Joshi, R Linnemann, ...
Journal of Cystic Fibrosis 20, S303, 2021
2021
667: Development of an iPSC-based airway epithelial platform for evaluating patient-specific responses to modulators
C Barillà, S Suzuki, A Rab, B Wang, J Hong, W Driggers, A Streby, ...
Journal of Cystic Fibrosis 20, S316, 2021
2021
AIRWAY BASAL CELLS: MAINTAINING STEM CELL PROPERTIES DURING DERIVATION AND EXPANSION
S Suzuki, C Barilla, F Hawkins, A Rab, M Beermann, N Matthias, ...
PEDIATRIC PULMONOLOGY 55, S236-S236, 2020
2020
APPLICATION OF IPSC-DERIVED AIRWAY EPITHELIUM FOR EVALUATING THE RESPONSE OF RARE OR UNKNOWN CFTR MUTATIONS TO MODULATORS
C Barilla, S Suzuki, A Rab, K Goller, JS Hong, WC Driggers, J Flores, ...
PEDIATRIC PULMONOLOGY 55, S193-S193, 2020
2020
IMPROVED FUNCTIONAL RESCUE OF G551D CFTR BY TRIPLE COMBINATION THERAPY
A Rab, S Suzuki, J Disha, C Barilla, K Goller, C Manfredi, JK Flores, ...
PEDIATRIC PULMONOLOGY 55, S188-S189, 2020
2020
IPS-DERIVED AIRWAY CELL RESPONSE TO CFTR MODULATION: STUDY OF TRIPLE COMBINATION THERAPY IN CF PATIENTS WITHOUT AN APPROVED MODULATOR
RW Linnemann, A Streby, A Rab, GM Solomon, E Hunter, T Hailemichael, ...
PEDIATRIC PULMONOLOGY 55, S207-S207, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–20